Delivery Order SPE2DB20D9331-SPE2DB21FL1D9

Award Date 5/20/21
Potential Completion Date 6/11/21
Potential Value $23K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $11,025.08 with a firm fixed-price pricing type. The award was made by the Defense Logistics Agency (DLA) under the Medical Supply Chain program to provide a wide range of pharmaceutical products and medical supplies, including medications, biologics, and consumables, to support the recurring medical needs of military health facilities worldwide....
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order valued at $82,417.09. The contract, awarded by the Defense Logistics Agency (DLA) under the Medical Supply Chain division, is part of a larger indefinite delivery contract (IDC) with the DLA valued at up to $499,999,999. This IDC, which runs through December 31, 2025, allows the DLA to issue delivery orders for a comprehensive range of...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $99,018.75 to DMS Pharmaceutical Group Inc., a woman-owned small business, to provide a range of pharmaceutical products and medical supplies to support the recurring medical needs of military healthcare facilities. This delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which enables the...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $25,929.00 for the provision of a wide range of pharmaceutical products and medical supplies to support the medical needs of military health facilities. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is part of the DLA's Medical Supply Chain division. The contract has no set-aside designation and is a firm...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a $30,043.74 firm fixed-price delivery order under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA) for the Medical Supply Chain program. The contract covers a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The $2,923.36 firm fixed-price delivery order contract is for the supply of a wide range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables. This award is part of a larger indefinite delivery contract...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) under the Medical Supply Chain division. The contract, valued at $12,934.05, is for the delivery of a range of pharmaceutical products including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to support the recurring medical supply needs of...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, provides for the delivery of a wide range of pharmaceutical products and medical supplies to the U.S. Defense Logistics Agency (DLA) in support of the Medical Supply Chain program. The $1,319.55 firm fixed-price delivery order has an ultimate completion date of October 9, 2024. DMS Pharmaceutical Group holds a larger $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
The Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the supply of pharmaceutical products including medications and medical supplies. The delivery order, valued at $2,494.50, has a completion date of September 13, 2022. This order is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group worth up to $499,999,999, which allows the DLA to issue...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business, is a firm fixed-price delivery order valued at $23,361.69 under a larger $499,999,999 indefinite delivery contract (IDC) with the Defense Logistics Agency (DLA). The contract covers the supply of a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables, to support the recurring medical supply...
  • SPE2DB20D9331
    Indefinite Delivery Contract
  • SPE2DB20D9331-SPE2DB21FL1D9
    Delivery Order

This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, was issued by the Defense Logistics Agency (DLA) for the Medical Supply Chain division. The $22,835.25 firm fixed-price delivery order is part of a larger $499,999,999 single-award indefinite delivery contract (IDC) that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of Department of Defense (DoD) healthcare facilities worldwide. The contract covers a vast array of products, from common medications to specialized drugs and medical supplies, supporting the diverse medical requirements of military personnel and their dependents across DoD facilities. This delivery order did not use a set-aside designation.

Generated 1/9/25, 9:11 AM